Genetic inactivation of the APC gene contributes to the malignant progression of sporadic hepatocellular carcinoma: A case report

Genes Chromosomes and Cancer

Volumn 45, Issue 11, 2006, Pages 1050-1057

  Katoh, Hiroto ^a   Shibata, Tatsuhiro ^a   Kokubu, Akiko ^a   Ojima, Hidenori ^a   Kosuge, Tomoo ^b   Kanai, Yae ^a   Hirohashi, Setsuo ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; BETA CATENIN; WNT PROTEIN;

ADULT; ADVANCED CANCER; ALLELE; APC GENE; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CASE REPORT; CHROMOSOME LOSS; CHROMOSOME STRUCTURE; CODON; COMPARATIVE GENOMIC HYBRIDIZATION; EARLY CANCER; GENE INACTIVATION; GENE LOCUS; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MALE; NONSENSE MUTATION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; TUMOR SUPPRESSOR GENE;

ALLELES; BETA CATENIN; CARCINOMA, HEPATOCELLULAR; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 17; DNA, NEOPLASM; GENE SILENCING; GENES, APC; HUMANS; LIVER NEOPLASMS; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; NUCLEIC ACID HYBRIDIZATION;

ARMADILLO;

EID: 33748921022     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20362     Document Type: Article

References (32)

1. Albuquerque C, Breukel C, van der Luijt R, Fidalgo P, Lage P, Slors FJ, Leitao CN, Fodde R, Smits R. 2002. The 'just-right' signaling model: APC somatic mutations are selected based on a specific level of activation of the β-catenin signaling cascade. Hum Mol Genet 11:1549-1560.
2. Bala S, Wunsch PH, Ballhausen WG. 1997. Childhood hepatocellular adenoma in familial adenomatous polyposis: Mutations in adenomatous polyposis coli gene and p53. Gastroenterology 112:919-922.
3. Cadoret A, Ovejero C, Terris B, Souil E, Levy L, Lamers WH, Kitajewski J, Kahn A, Perret C. 2002. New targets of β-catenin signaling in the liver are involved in the glutamine metabolism. Oncogene 21:8293-8301.
4. Chen TC, Hsieh LL, Ng KF, Jeng LB, Chen MF. 1998. Absence of APC gene mutation in the mutation cluster region in hepatocellular carcinoma. Cancer Lett 134:23-28.
5. Colnot S, Decaens T, Niwa-Kawakita M, Godard C, Hamard G, Kahn A, Giovannini M, Perret C. 2004. Liver-targeted disruption of Apc in mice activates β-catenin signaling and leads to hepatocellular carcinomas. Proc Natl Acad Sci USA 101:17216-17221.
6. de La Coste A, Romagnolo B, Billuart P, Renard CA, Buendia MA, Soubrane O, Fabre M, Chelly J, Beldjord C, Kahn A, Perret C. 1998. Somatic mutations of the β-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc Natl Acad Sci USA 95:8847-8851.
7. Groden J, Thliveris A, Samowitz W, Carlson M, Gelbert L, Albertsen H, Joslyn G, Stevens J, Spirio L, Robertson M, Sargeant L, Krapcho K, Wolff E, Burt R, Hughes JP, Warrington J, McPherson J, Wasmuth J, Le Paslier D, Abderrahim H, Cohen D, Leppert M, White R. 1991. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 66:589-600.
8. Gruner BA, DeNapoli TS, Andrews W, Tomlinson G, Bowman L, Weitman SD. 1998. Hepatocellular carcinoma in children associated with Gardner syndrome or familial adenomatous polyposis. J Pediatr Hematol Oncol 20:274-278.
9. Henderson BR. 2000. Nuclear-cytoplasmic shuttling of APC regulates β-catenin subcellular localization and turnover. Nat Cell Biol 2:653-660.
10. Ishizaki Y, Ikeda S, Fujimori M, Shimizu Y, Kurihara T, Itamoto T, Kikuchi A, Okajima M, Asahara T. 2004. Immunohistochemical analysis and mutational analyses of β-catenin, Axin family and APC genes in hepatocellular carcinomas. Int J Oncol 24:1077-1083.
11. Katoh H, Shibata T, Kokubu A, Ojima H, Loukopoulos P, Kanai Y, Kosuge T, Fukayama M, Kondo T, Sakamoto M, Hosoda F, Ohki M, Imoto I, Inazawa J, Hirohashi S. 2005. Genetic profile of hepatocellular carcinoma revealed by array-based comparative genomic hybridization: Identification of genetic indicators to predict patient outcome. J Hepatol 43:863-874.
12. Kielman MF, Rindapaa M, Gaspar C, van Poppel N, Breukel C, van Leeuwen S, Taketo MM, Roberts S, Smits R, Fodde R. 2002. Apc modulates embryonic stem-cell differentiation by controlling the dosage of β-catenin signaling. Nat Genet 32:594-605.
13. Kondo Y, Kanai Y, Sakamoto M, Genda T, Mizokami M, Ueda R, Hirohashi S. 1999. β-Catenin accumulation and mutation of exon 3 of the β-catenin gene in hepatocellular carcinoma. Jpn J Cancer Res 90:1301-1309.
14. Lamlum H, Ilyas M, Rowan A, Clark S, Johnson V, Bell J, Frayling I, Efstathiou J, Pack K, Payne S, Roylance R, Gorman P, Sheer D, Neale K, Phillips R, Talbot I, Bodmer W, Tomlinson I. 1999. The type of somatic mutation at APC in familial adenomatous polyposis is determined by the site of the germline mutation: A new facet to Knudson's 'two-hit' hypothesis. Nat Med 5:1071-1075.
15. Llovet JM, Burroughs A, Bruix J. 2003. Hepatocellular carcinoma. Lancet 362:1907-1917.
16. Merle P, de la Monte S, Kim M, Herrmann M, Tanaka S, Von Dem Bussche A, Kew MC, Trepo C, Wands JR. 2004. Functional consequences of frizzled-7 receptor overexpression in human hepatocellular carcinoma. Gastroenterology 127:1110-1122.
17. Merle P, Kim M, Herrmann M, Gupte A, Lefrancois L, Califano S, Trepo C, Tanaka S, Vitvitski L, de la Monte S, Wands JR. 2005. Oncogenic role of the frizzled-7/β-catenin pathway in hepatocellular carcinoma. J Hepatol 43:854-862.
18. Miyoshi Y, Nagase H, Ando H, Horii A, Ichii S, Nakatsuru S, Aoki T, Miki Y, Mori T, Nakamura Y. 1992. Somatic mutations of the APC gene in colorectal tumors: Mutation cluster region in the APC gene. Hum Mol Genet 1:229-233.
19. Nagase H, Nakamura Y. 1993. Mutations of the APC (adenomatous polyposis coli) gene. Hum Mutat 2:425-434.
20. Oda T, Tsuda H, Sakamoto M, Hirohashi S. 1994. Different mutations of the p53 gene in nodule-in-nodule hepatocellular carcinoma as a evidence for multistage progression. Cancer Lett 83:197-200.
21. Park JY, Park WS, Nam SW, Kim SY, Lee SH, Yoo NJ, Lee JY, Park CK. 2005. Mutations of β-catenin and AXIN I genes are a late event in human hepatocellular carcinogenesis. Liver Int 25:70-76.
22. Reya T, Clevers H. 2005. Wnt signalling in stem cells and cancer. Nature 434:843-850.
23. Rosin-Arbesfeld R, Cliffe A, Brabletz T, Bienz M. 2003. Nuclear export of the APC tumour suppressor controls β-catenin function in transcription. EMBO J 22:1101-1113.
24. Rowan AJ, Lamlum H, Ilyas M, Wheeler J, Straub J, Papadopoulou A, Bicknell D, Bodmer WF, Tomlinson IP. 2000. APC mutations in sporadic colorectal tumors: A mutational "hotspot" and interdependence of the "two hits". Proc Natl Acad Sci USA 97:3352-3357.
25. Sakamoto M, Hirohashi S, Shimosato Y. 1991. Early stages of multi-step hepatocarcinogenesis: Adenomatous hyperplasia and early hepacocellular carcinoma. Hum Pathol 22:172-178.
26. Soussi T, Ishioka C, Claustres M, Beroud C. 2006. Locus-specific mutation databases: Pitfalls and good practice based on the p53 experience. Nat Rev Cancer 6:83-90.
27. Sparks AB, Morin PJ, Vogelstein B, Kinzler KW. 1998. Mutational analysis of the APC/β-catenin/Tcf pathway in colorectal cancer. Cancer Res 58:1130-1134.
28. Su LK, Abdalla EK, Law CH, Kohlmann W, Rashid A, Vauthey JN. 2001. Biallelic inactivation of the APC gene is associated with hepatocellular carcinoma in familial adenomatous polyposis coli. Cancer 92:332-339.
29. Takayama T, Makuuchi M, Hirohashi S, Sakamoto M, Okazaki N, Takayasu K, Kosuge T, Motoo Y, Yamazaki S, Hasegawa H. 1990. Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma. Lancet 336:1150-1153.
30. Taniguchi K, Roberts LR, Aderca IN, Dong X, Qian C, Murphy LM, Nagorney DM, Burgart LJ, Roche PC, Smith DI, Ross JA, Liu W. 2002. Mutational spectrum of β-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas. Oncogene 21:4863-4871.
31. Thorgeirsson SS, Grisham JW. 2002. Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 31:339-346.
32. Tsuda H, Hirohashi S, Shimosato Y, Terada M, Hasegawa H. 1988. Clonal origin of atypical adenomatous hyperplasia of the liver and clonal identity with hepatocellular carcinoma. Gastroenterology 95:1664-1666.